Invesco Ltd. Connect Biopharma Holdings LTD Transaction History

Invesco Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.56 - $3.25 $33,851 - $196,459	-60,449 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.46 - $5.92 $85,657 - $206,134	34,820 Added 135.86%	60,449 $183,000
Q4 2021 Feb 14, 2022	BUY	$4.26 - $23.33 $70,588 - $386,578	16,570 Added 182.91%	25,629 $132,000
Q3 2021 Nov 15, 2021	BUY	$18.12 - $28.5 $164,149 - $258,181	9,059 New	9,059 $219,000

3.05M

Ticker CNTB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,015,800
Market Cap $55M
Description
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.